This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlueter, V.
Right arrow Articles by Engel, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlueter, V.
Right arrow Articles by Engel, A. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 11 1996, 2660-2664, Vol 34, No. 11
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Reverse transcription-PCR detection of hepatitis G virus

V Schlueter, S Schmolke, K Stark, G Hess, B Ofenloch-Haehnle and AM Engel
Boehringer Mannheim GmbH, R&D Infectious Diseases, Penzberg, Germany.

Hepatitis G virus (HGV) was recently identified as a new member of the Flaviviridae, but its clinical significance is still unclear. Since no immunoassay for the diagnosis of HGV is available, we developed a sensitive reverse transcription-PCR (RT-PCR) assay to facilitate the detection of the viral genome by mass screening in the clinical laboratory. Sequences within the 5'-noncoding region and within the putative NS5a region are independently amplified in the presence of digoxigenin-11-dUTP and are detected by hybridization with biotinylated capture probes binding to a streptavidin-coated matrix. Semiquantitative Enzymun-Test DNA detection via chemiluminescence can be performed either in a microtiter plate format or on fully automated ES 300 machines. We were able to detect at least 8 x 10(2) genome equivalents per ml of serum using both primer pairs. HGV was shown to be present in 43 of 130 (33%) serum samples from intravenous drug abusers with a high risk of parenteral exposure. However, only two of the patients were positive when the NS5a primers only were used, and only one patient was positive when only the 5'-noncoding region primers were used, demonstrating the increased sensitivity of HGV detection with two sets of primers. Among these patients, there was no obvious correlation with other viral infections like hepatitis B virus, hepatitis C virus, or human immunodeficiency virus. Within a blood donor panel, 3 of 92 (3%) samples were found to be HGV positive, suggesting that donated blood may need to be screened for HGV.


This article has been cited by other articles:

  • Munoz, S. J., Alter, H. J., Nakatsuji, Y., Shih, J. W.-K., Reddy, R. K., Jeffers, L., Schiff, E. R., Reid, A. E., Marrone, A., Rothstein, K., Manzarbeitia, C., Liang, T. J. (1999). The Significance of Hepatitis G Virus in Serum of Patients With Sporadic Fulminant and Subfulminant Hepatitis of Unknown Etiology. Blood 94: 1460-1464 [Abstract] [Full Text]  
  • Schmolke, S., Tacke, M., Schmitt, U., Engel, A. M., Ofenloch-Haehnle, B. (1998). Identification of Hepatitis G Virus Particles in Human Serum by E2-Specific Monoclonal Antibodies Generated by DNA Immunization. J. Virol. 72: 4541-4545 [Abstract] [Full Text]  
  • Pujol, F. H., Khudyakov, Y. E., Devesa, M., Cong, M.-E., Loureiro, C. L., Blitz, L., Capriles, F., Beker, S., Liprandi, F., Fields, H. A. (1998). Hepatitis G Virus Infection in Amerindians and Other Venezuelan High-Risk Groups. J. Clin. Microbiol. 36: 470-474 [Abstract] [Full Text]  
  • SAULEDA, S, RIO, J, MONTALBAN, X, MARTINEZ-CACERES, E, ESTEBAN, J., GUARDIA, J (1998). Lack of association between hepatitis G virus and multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 64: 283-284 [Full Text]  
  • Prati, D., Zanella, A., Bosoni, P., Rebulla, P., Farma, E., De Mattei, C., Capelli, C., Mozzi, F., Gallisai, D., Magnano, C., Melevendi, C., e Cooleycare Cooperative Group, G. S. f. t. (1998). The Incidence and Natural Course of Transfusion-Associated GB Virus C/Hepatitis G Virus Infection in a Cohort of Thalassemic Patients. Blood 91: 774-777 [Abstract] [Full Text]  
  • Andonov, A, Sauder, C, Jacobsen, H, Chaudhary, R (1998). Comparison of six sets of PCR primers from two different genomic regions for amplification of GB virus C/hepatitis G virus RNA [In Process Citation]. J. Clin. Microbiol. 36: 286-289 [Abstract] [Full Text]